Rejuvesol

Citra Labs, LLC🇺🇸 United States

FDA Page

Effective Date: Feb 14, 2023
Approval ID: bc06c40f-81a0-45e5-80b6-61f67d445068
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

rejuvesol red blood cell processing solution

Quick Stats

Total Products1

Labelers2

Label Sections15

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.